Cargando…

重组人血管内皮抑制素联合贝伐珠单抗体内抑瘤作用的效果及分析

BACKGROUND AND OBJECTIVE: The aim of this study is to investigate difference of antiangiogenesis ablility and interaction about bevacizumab and endostatin in vivo in lung cancer animal model. METHODS: First, we construct a Balb/c mice model with A549 lung adenocarcinoma cell. Then, we divide the mic...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000393/
https://www.ncbi.nlm.nih.gov/pubmed/23425896
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.01